Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

984
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
984
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

47.1K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.1K
Viral Mutations00:36

Viral Mutations

33.7K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
33.7K
Retroviruses02:33

Retroviruses

12.7K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.7K
Subviral Agents01:29

Subviral Agents

147
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
147

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Population-scale chemical response revealed by a barcoded yeast collection.

Nature communications·2026
Same author

A Physics-Informed Neural Network (PINN) Approach to Over-Equilibrium Dynamics in Conservatively Perturbed Linear Equilibrium Systems.

Entropy (Basel, Switzerland)·2026
Same author

Domestication drives repeated evolution of sexual-asexual life cycle trade-offs in yeast.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

An empirical long-term competition among natural yeast isolates reveals that short-term fitness largely but not entirely predicts long-term outcomes.

bioRxiv : the preprint server for biology·2025
Same author

Shaping robust dynamic inversion control of neural cell dynamics.

Biomedical physics & engineering express·2025
Same author

Developing a Zn(II)-metallovesicle for loading and delivering doxorubicin to kill cancer cells-a multi-drug delivery system.

Chemical communications (Cambridge, England)·2025

Related Experiment Video

Updated: Sep 25, 2025

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

1.9K

Optimizing antiviral therapy for COVID-19 with learned pathogenic model.

Abhishek Dutta1

  • 1Department of Electrical & Computer Engineering, Storrs, 06269, USA. abhishek.dutta@uconn.edu.

Scientific Reports
|April 28, 2022
PubMed
Summary

This study introduces a new model for COVID-19 dynamics and drug rescheduling. It significantly reduced remdesivir dosage and toxicity while maintaining high efficacy against SARS-CoV-2.

More Related Videos

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.5K
Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

6.2K

Related Experiment Videos

Last Updated: Sep 25, 2025

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses
05:49

Author Spotlight: Studying Host-Virus Interactions with Pseudotyped Viruses

Published on: November 21, 2023

1.9K
Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.5K
Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
05:23

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization

Published on: December 23, 2020

6.2K

Area of Science:

  • Virology
  • Pharmacology
  • Computational Biology

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused global health and economic crises.
  • Existing treatments for coronavirus disease 2019 (COVID-19) lack proven efficacy, and insights into pathogenesis and antiviral pharmacology are limited.
  • Repurposed antivirals are being investigated, but optimal dosing and scheduling remain critical challenges.

Purpose of the Study:

  • To develop a systematic pathological model for COVID-19 dynamics.
  • To optimize antiviral drug rescheduling using derivative-free optimization.
  • To reduce toxicity and maintain virological efficacy of treatments like remdesivir.

Main Methods:

  • Systematic pathological model learning from clinical data of severe COVID-19 patients.
  • Derivative-free optimization for multi-objective drug rescheduling.
  • Prediction of immune T cells response integrated into the pathological model.

Main Results:

  • The pathological model accurately predicted immune T cells response.
  • Optimized remdesivir dose and schedule led to a dramatic reduction in toxicity.
  • High virological efficacy was maintained despite reduced drug dosage.

Conclusions:

  • Systematic pathological modeling offers a novel approach to understanding COVID-19 dynamics.
  • Derivative-free optimization enables effective drug rescheduling for reduced toxicity.
  • This strategy holds promise for improving the safety and efficacy of antiviral therapies for COVID-19 and future pandemics.